Dupilumab Step-down Strategy to Maintain Remission in Adult and Adolescents Patients With Atopic Dermatitis
NCT05642208
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Amiens, France
View Trial DetailsNCT Number: NCT01238263
Recently, IgE-type autoantibodies against self proteins have been detected in the serum of the atopic dermatitis patients. The role of this IgE autoantibodies involved in the pathogenesis of atopic dermatitis is not known, yet. But, there may be a correlation between the severity of the disease and the serum levels of this autoantibodies. The autologous serum skin testing is applied to both atopic dermatitis patients and healthy control and the results are estimated in this study.The investigators detected 70% positive autologous serum skin testing in atopic dermatitis patients and test positivity was higher in patients with atopy history, moderately severe disease calculated by SCORAD index and high serum IgE levels.
Looking for future studies?
Notify Me1 year–45 year
All sexes
Observational
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Looking for future studies?
Notify MeYuzuncu Yil University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05642208
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Amiens, France
View Trial DetailsNCT07839897
Atopic Dermatitis (AD), Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Rio de Janeiro, Brazil
View Trial DetailsNCT07009483
Atopic Dermatitis (AD), Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Edmonton, Alberta, Canada
View Trial DetailsNCT06554847
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis
Shanghai, Shanghai Municipality, China
View Trial Details